Deletion of Ptpn1 induces myeloproliferative neoplasm.
作者信息
Jobe F, Patel B, Kuzmanovic T, Makishima H, Yang Y, Przychodzen B, Hutchison R E, Bence K K, Maciejewski J P, Mohi G
机构信息
Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, USA.
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
出版信息
Leukemia. 2017 May;31(5):1229-1234. doi: 10.1038/leu.2017.31. Epub 2017 Jan 23.
Abstract
摘要
相似文献
1
Deletion of Ptpn1 induces myeloproliferative neoplasm.
Leukemia. 2017 May;31(5):1229-1234. doi: 10.1038/leu.2017.31. Epub 2017 Jan 23.
2
7q22 deletion in myeloid malignancies: be attentive to the design of the FISH probe.
Ann Biol Clin (Paris). 2019 Apr 1;77(2):229-230. doi: 10.1684/abc.2019.1425.
3
Prognostic significance of del(20q) in patients with hematological malignancies.
Cancer Genet Cytogenet. 2005 Jul 15;160(2):188-92. doi: 10.1016/j.cancergencyto.2004.12.019.
4
Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
Ann Hematol. 2008 Jul;87(7):537-44. doi: 10.1007/s00277-008-0462-3. Epub 2008 Mar 19.
5
Genomic analysis of clonal eosinophils by CGH arrays reveals new genetic regions involved in chronic eosinophilia.
Eur J Haematol. 2014 Nov;93(5):422-8. doi: 10.1111/ejh.12379. Epub 2014 Jun 26.
6
Issue Highlights - July 2019.
Cytometry B Clin Cytom. 2019 Jul;96(4):253-255. doi: 10.1002/cyto.b.21836.
7
Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution.
Am J Hematol. 2010 Apr;85(4):238-42. doi: 10.1002/ajh.21631.
8
The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis.
Hematol Oncol Clin North Am. 2009 Aug;23(4):693-708. doi: 10.1016/j.hoc.2009.04.002.
9
Jak2V617F driven myeloproliferative neoplasm occurs independently of interleukin-3 receptor beta common signaling.
Haematologica. 2016 Mar;101(3):e77-80. doi: 10.3324/haematol.2015.136705. Epub 2015 Nov 20.
10
Translocation (X;20) involving the inactive X chromosome in a patient with myeloproliferative disorder.
Cancer Genet Cytogenet. 2005 Apr 1;158(1):81-3. doi: 10.1016/j.cancergencyto.2004.08.029.
引用本文的文献
1
Protein tyrosine phosphatase 1B in metabolic diseases and drug development.
Nat Rev Endocrinol. 2024 Jun;20(6):366-378. doi: 10.1038/s41574-024-00965-1. Epub 2024 Mar 22.
2
Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling.
Thorac Cancer. 2022 Nov;13(21):3042-3051. doi: 10.1111/1759-7714.14657. Epub 2022 Oct 4.
3
Biochemical, Enzymatic, and Computational Characterization of Recurrent Somatic Mutations of the Human Protein Tyrosine Phosphatase PTP1B in Primary Mediastinal B Cell Lymphoma.
Int J Mol Sci. 2022 Jun 24;23(13):7060. doi: 10.3390/ijms23137060.
4
Hippo kinase loss contributes to del(20q) hematologic malignancies through chronic innate immune activation.
Blood. 2019 Nov 14;134(20):1730-1744. doi: 10.1182/blood.2019000170.
5
Deficiency in Protein Tyrosine Phosphatase PTP1B Shortens Lifespan and Leads to Development of Acute Leukemia.
Cancer Res. 2018 Jan 1;78(1):75-87. doi: 10.1158/0008-5472.CAN-17-0946. Epub 2017 Nov 9.
本文引用的文献
1
A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients.
Br J Haematol. 2015 Apr;169(1):71-6. doi: 10.1111/bjh.13260. Epub 2014 Dec 17.
2
Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasm.
J Clin Invest. 2014 Jun;124(6):2762-73. doi: 10.1172/JCI74182. Epub 2014 May 8.
3
Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma.
Nat Genet. 2014 Apr;46(4):329-35. doi: 10.1038/ng.2900. Epub 2014 Feb 16.
4
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy.
Elife. 2013 Jul 16;2:e00825. doi: 10.7554/eLife.00825.
5
AKT is a therapeutic target in myeloproliferative neoplasms.
Leukemia. 2013 Sep;27(9):1882-90. doi: 10.1038/leu.2013.167. Epub 2013 Jun 10.
6
Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions.
J Clin Invest. 2013 May;123(5):2169-82. doi: 10.1172/JCI66113. Epub 2013 Apr 1.
7
Critical requirement for Stat5 in a mouse model of polycythemia vera.
Blood. 2012 Apr 12;119(15):3539-49. doi: 10.1182/blood-2011-03-345215. Epub 2011 Dec 5.
8
Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
Genes Chromosomes Cancer. 2010 Apr;49(4):390-9. doi: 10.1002/gcc.20748.
9
Myeloproliferative disorders.
Blood. 2008 Sep 15;112(6):2190-8. doi: 10.1182/blood-2008-03-077966.
10
Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis.
Nat Genet. 2007 Mar;39(3):338-46. doi: 10.1038/ng1963. Epub 2007 Jan 28.
Zotero 插件